The recent withdrawal of the USA from the Paris Agreement by President Donald Trump marks a significant turning point in ...

Roche has exercised its option to license a novel capsid from Dyno Therapeutics for use in a gene therapy program for an ...

The extended agreement, effective Dec. 20 ... The company also put down a security deposit of roughly $176,000. Vector Group, Elliman’s former parent company, rented the space from Frost ...

CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...

Brics has emerged as a significant international force since 2009 when it was established at a summit in Russia. What began ...

Haas have signed a key figure from Alpine to manage the team's relationship with Toyota amid mounting rumours of a ...

UN agencies have responded to President Trump’s executive orders ending US membership of the World Health Organization (WHO) ...

The Open Network Foundation, a non-profit supporting the TON blockchain, has become the exclusive partner for Telegram's mini-app platform.

The partners will adapt Eukarÿs' C3P3 engineered enzyme tech to work with adeno-associated virus vectors to boost biomanufacturing yields.

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will participate in the ...